Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-17

FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for atorvastatin calcium (generic) from Ascend Laboratories, LLC, for this ANDA, approving regulatory changes associated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)